Chemical Informatics and Target Identification in a Zebrafish Phenotypic Screen
暂无分享,去创建一个
Bryan L. Roth | Brian K. Shoichet | Michael J. Keiser | Christian Laggner | John J. Irwin | Daniel L. Minor | J. Irwin | B. Shoichet | V. Setola | B. Roth | C. Laggner | A. Tolia | R. Peterson | D. Minor | D. Kokel | Henry Lin | Randall T. Peterson | David Kokel | Chung Yan J. Cheung | Henry Lin | C. Y. J. Cheung | Vincent Setola | Alexandra Tolia | Christian Laggner | Alexandra Tolia | Henry Lin | Chung Yan J. Cheung | Daniel L. Minor | Bryan L. Roth | Randall T. Peterson
[1] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[2] Tudor I. Oprea,et al. Quantifying the Relationships among Drug Classes , 2008, J. Chem. Inf. Model..
[3] Michael J. Keiser,et al. The Chemical Basis of Pharmacology , 2010, Biochemistry.
[4] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[5] S. Haggarty,et al. Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. , 2000, Chemistry & biology.
[6] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[7] Christian Laggner,et al. Rapid behavior—based identification of neuroactive small molecules in the zebrafish , 2009, Nature chemical biology.
[8] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[9] John A. Tallarico,et al. Integrating high-content screening and ligand-target prediction to identify mechanism of action. , 2008, Nature chemical biology.
[10] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[11] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[12] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[13] S. Schreiber,et al. A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.
[14] Dale L Boger,et al. Discovering potent and selective reversible inhibitors of enzymes in complex proteomes , 2003, Nature Biotechnology.
[15] Jérôme Hert,et al. Quantifying Biogenic Bias in Screening Libraries , 2009, Nature chemical biology.
[16] S. Haggarty,et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. , 1999, Science.
[17] P. Hergenrother,et al. Transcript profiling and RNA interference as tools to identify small molecule mechanisms and therapeutic potential. , 2011, ACS chemical biology.
[18] Martin Serrano,et al. Nucleic Acids Research Advance Access published October 18, 2007 ChemBank: a small-molecule screening and , 2007 .
[19] Philip E. Bourne,et al. Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis , 2009, PLoS Comput. Biol..
[20] Stuart L Schreiber,et al. Small molecules: the missing link in the central dogma , 2005, Nature chemical biology.
[21] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[22] R. Coupland. Progress in Catecholamine Research , 1990 .
[23] Steven A Carr,et al. Identifying the proteins to which small-molecule probes and drugs bind in cells , 2009, Proceedings of the National Academy of Sciences.
[24] R. Solé,et al. The topology of drug-target interaction networks: implicit dependence on drug properties and target families. , 2009, Molecular bioSystems.